M&A / Deals Amneal Agrees to Acquire Kashiv BioSciences for Total Payment up to $1.1 Billion Big Molecule WatchOn April 22, 2026 Amneal Pharmaceuticals, Inc.Read full story pharminent May 4, 2026 (Last updated: May 5, 2026) Big Molecule Watch On April 22, 2026 Amneal Pharmaceuticals, Inc. Read full story Post navigation Previous: Part D Mail Order Prescription DrugsNext: Cytospire hauls in $83M for a new type of T cell engager Related Stories M&A / Deals Solstice Oncology secures $225m to drive porustobart’s development for cancer pharminent September 10, 2026 M&A / Deals UK’s Claret Capital raises 575m for European biotechs pharminent September 7, 2026 M&A / Deals GSK wagers up to $1.3B on a different kind of cancer drug pharminent September 3, 2026